NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Huayi Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
81%
Finnrick rating
#44 of 500 ranked vendors
44 of 47 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Huayi Biotechnology's purity-focus record is strongest for GHK-Cu and Tirzepatide, with Retatrutide improving after earlier purity misses. BPC-157 is the weak spot after a recent purity miss; results are fairly broad and current, but missing batch IDs and notable fill swings keep the evidence less settled.

methodology →
vendor intelligence report
Vendor Intelligence Report: Huayi Biotechnology

Huayi’s footprint splits between a closed Shoplazza storefront and an active Shop910-backed domain with cloaking and special-payment features. The report traces Tongkang-linked certificates, SV-branded vials, and review redirects while the true operator remains unresolved.

26 pages7 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Sep 2025: 65%30 Sep 2025: 66%9 Oct 2025: 67%9 Oct 2025: 66%21 Oct 2025: 65%6 Jan 2026: 71%7 Jan 2026: 72%7 Jan 2026: 72%26 Jan 2026: 73%26 Jan 2026: 73%2 Feb 2026: 75%11 Feb 2026: 75%11 Feb 2026: 75%11 Feb 2026: 76%16 Feb 2026: 76%18 Feb 2026: 76%22 Feb 2026: 77%1 Mar 2026: 77%2 Mar 2026: 77%3 Mar 2026: 77%6 Mar 2026: 77%10 Mar 2026: 77%16 Mar 2026: 78%18 Mar 2026: 78%18 Mar 2026: 78%18 Mar 2026: 78%29 Mar 2026: 78%23 Apr 2026: 79%28 Apr 2026: 79%8 May 2026: 79%6 Jun 2026: 79%12 Jun 2026: 80%15 Jun 2026: 80%16 Jun 2026: 80%8 Sep 2026: 80%15 Sep 2026: 80%30 Sep 2026: 80%6 Oct 2026: 81%6 Oct 2026: 81%23 Oct 2026: 81%17 Nov 2026: current 81%65%76%81%Sep 25Nov 26
Peptide testing

Ordered peptides from Huayi Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
Huayi Biotechnology test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
23 Oct 2026
Pass
Tirzepatide
lab nameView COA
6 Oct 2026
Pass
BPC-157
lab nameView COA
6 Oct 2026
Pass
GHK-Cu
lab nameView COA
30 Sep 2026
Pass
Retatrutide
lab nameView COA
15 Sep 2026
Pass
GHK-Cu
lab nameView COA
8 Sep 2026
Pass
Retatrutide
lab nameView COA
16 Jun 2026
Pass
Retatrutide
lab nameView COA
15 Jun 2026
Pass
Tirzepatide
lab nameView COA
12 Jun 2026
Pass
Retatrutide
lab nameView COA
6 Jun 2026
Pass
Retatrutide
lab nameView COA
1-10 of 48

About Huayi Biotechnology test results from Finnrick

Huayi Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 48 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Huayi Biotechnology peptides in this dataset are Tirzepatide (11 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 48 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Huayi Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply